Sodium channelopathies in neurodevelopmental disorders
The voltage-gated sodium channel α-subunit genes comprise a highly conserved gene
family. Mutations of three of these genes, SCN1A, SCN2A and SCN8A, are responsible for a …
family. Mutations of three of these genes, SCN1A, SCN2A and SCN8A, are responsible for a …
Metabolic dysfunction and oxidative stress in epilepsy
JN Pearson-Smith, M Patel - International Journal of Molecular Sciences, 2017 - mdpi.com
The epilepsies are a heterogeneous group of disorders characterized by the propensity to
experience spontaneous recurrent seizures. Epilepsies can be genetic or acquired, and the …
experience spontaneous recurrent seizures. Epilepsies can be genetic or acquired, and the …
Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial
R Nabbout, A Mistry, S Zuberi, N Villeneuve… - JAMA …, 2020 - jamanetwork.com
Importance Fenfluramine treatment may reduce monthly convulsive seizure frequency in
patients with Dravet syndrome who have poor seizure control with their current stiripentol …
patients with Dravet syndrome who have poor seizure control with their current stiripentol …
Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial
I Miller, IE Scheffer, B Gunning… - JAMA …, 2020 - jamanetwork.com
Importance Clinical evidence supports effectiveness of cannabidiol for treatment-resistant
seizures in Dravet syndrome, but this trial is the first to evaluate the 10-mg/kg/d dose …
seizures in Dravet syndrome, but this trial is the first to evaluate the 10-mg/kg/d dose …
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
Objective Add‐on cannabidiol (CBD) significantly reduced seizures associated with Dravet
syndrome (DS) in a randomized, double‐blind, placebo‐controlled trial: GWPCARE1 Part B …
syndrome (DS) in a randomized, double‐blind, placebo‐controlled trial: GWPCARE1 Part B …
Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
KH Lim, Z Han, HY Jeon, J Kach, E **g… - Nature …, 2020 - nature.com
While most monogenic diseases are caused by loss or reduction of protein function, the
need for technologies that can selectively increase levels of protein in native tissues …
need for technologies that can selectively increase levels of protein in native tissues …
De novo variants in neurodevelopmental disorders with epilepsy
Epilepsy is a frequent feature of neurodevelopmental disorders (NDDs), but little is known
about genetic differences between NDDs with and without epilepsy. We analyzed de novo …
about genetic differences between NDDs with and without epilepsy. We analyzed de novo …
[HTML][HTML] Opposing effects on NaV1. 2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures
Background Variants in the SCN2A gene that disrupt the encoded neuronal sodium channel
Na V 1.2 are important risk factors for autism spectrum disorder (ASD), developmental delay …
Na V 1.2 are important risk factors for autism spectrum disorder (ASD), developmental delay …
Epilepsy-related voltage-gated sodium channelopathies: a review
LFS Menezes, EF Sabiá Júnior, DV Tibery… - Frontiers in …, 2020 - frontiersin.org
Epilepsy is a disease characterized by abnormal brain activity and a predisposition to
generate epileptic seizures, leading to neurobiological, cognitive, psychological, social, and …
generate epileptic seizures, leading to neurobiological, cognitive, psychological, social, and …
De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP
Individuals with severe, sporadic disorders of infantile onset represent an important class of
disease for which discovery of the underlying genetic architecture is not amenable to …
disease for which discovery of the underlying genetic architecture is not amenable to …